Redeye is encouraged by the announcement of a strategic restructuring of Champion Health Plus. The restructuring, which reduces 25 physical clinics and replaces many of the in-clinic services with the new AI-based triage platform Nexa, is expected to result in a net EUR0.2 annual profitability gain. We have updated our estimates to account for the financial impact, yet our valuation remains intact with a Base case fair value of SEK23.
LÄS MER